Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

Clinical trial NCT06190067 · RECRUITING

Trial details

NCT number: NCT06190067
Sponsor: Navy General Hospital, Beijing
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Classic Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma

Start date: 2023-10-30
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.